Egalet (STU:EGP) Marketable Securities: €0.00 Mil (As of Mar. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Egalet Marketable Securities?

Egalet STU:EGP Marketable Securities is €0.00 Mil as of Mar. 2020. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Egalet's Marketable Securities for the quarter that ended in Mar. 2020 was €0.00 Mil.

Egalet's annual Marketable Securities declined from Dec. 2017 (€50.66 Mil) to Dec. 2018 (€4.38 Mil) and declined from Dec. 2018 (€4.38 Mil) to Dec. 2019 (€0.00 Mil).

Egalet  (STU:EGP) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Egalet Marketable Securities Related Terms

Egalet Marketable Securities Historical Data

* Premium members only.

The historical data trend for Egalet's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egalet Marketable Securities Chart

Egalet Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 90.92 40.26 50.66 4.38 0.00

Egalet Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Egalet Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.00 Mil mean?
Egalet (STU:EGP) has a Marketable Securities of €0.00 Mil as of Mar. 2020. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Egalet and its competitors.
Is Egalet's Marketable Securities too high?
Egalet's current Marketable Securities is €0.00 Mil.
How does Egalet's Marketable Securities compare to CPHI and TLGT?
Egalet's Marketable Securities of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Egalet and its competitors. Egalet's current Marketable Securities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egalet stock overvalued right now?
Egalet (STU:EGP) has a current Marketable Securities of €0.00 Mil. The current Marketable Securities is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Egalet (STU:EGP), the current Marketable Securities is €0.00 Mil as of Mar. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Egalet Business Description

Address 600 Lee Road, Suite 100, Wayne, PA, USA, 19087
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.